Re
li he Phil Philip ippi pine ne Department of Health
Directline:
AD
E-mail:
AT
[email protected]
DE
Rationale
I.
prov provin ince ces. s. 100,00 100,00
In 20 7, th
nt
ealt ealthh-
la ia
ontr ontrol ol
og am
popula populatio tion. n.
ul ad xine xine-P -Pyr yrim im th
Plas Plasmo modi dium um th
epar epar
in
(S
on th rapy rapy to
+S
co bi atio atio
as th
inte interi ri
falc falcip ipar arum um
firs firs line line trea treatm tmen ent. t.
10 nzan nzania ia
nd La
ople ople's 's
oc atic atic
epub epubli lic. c.
Fiel Fiel Heal Health th Serv Servic ic Info Inform rmat atio io Syst System em Depa Depart rtme ment nt of Heal Health th 2006 2006 Prog Progra ra Acco Accomp mpli lish shme ment nt Repo Report rt Mala Malari ri Cont Contro ro Prog Progra ram, m, Depa Depart rtme ment nt of Heal Health th May. May. 2003 2003 00
H O G ui ui de de lili ne ne s o r t h T re re at at me me n o f
al ri
artemisinin-based suppositories." ex
ea
ur
an
et
ma aria ncidence in th Ph lippines by 2015
II
il be atta ned.
eclaration of Policy
al coun ry he exis in ed up
adopte
en
15
ns
po ic an guidel ne on th diagnosi an ea
es
reatment of ma aria
nationwide as th first-line treatment.
III. Guidin
Principles
Th implementation of th update policy an gu de in on diagnosi an trea ment of malari shal be guided by th followin principles on
A.
bj
no
nd
at
Th
revise
anti-malar al
us al on pe ul nd ag approaches in othe countrie will be reviewed fo possible adoption B. Primar
co
Health Care Approach Th diagnosi an treatmen of malari must
at communities;
he
C. Universa Access alar po
iv
nt
or
ng
al
diagnostic an treatmen serv ce gu el ne us ad av
00 WH Gudein f o t h T re at me n o f M al ar i Artemisinin-base suppositories, Report of WH Informal Consultation 27-2 WHO/HTM/MAU2006.1118
Marc
accordance
2006 Geneva
indigenous peoples, soldiers etc. D. In egra ed
Se vice
elivery. The provision
er
of de
servic delivery integratio at th loca level; E. Health System Support.
of
training of health provider an establishmen of qualit assurance. F. Multi-Sectoral Collaboration. di ferent sector ducation
at al leve
of operat ons. Effo ts of concerne
ep d, Na iona An -Pover
Co miss on
office
rmed Fo ce of he
different stakeholders
IV
Objectives
trea ment of al
alar
update
case
he country.
pecifica ly
ai
o:
diagnosi an treatmen of malaria;
pr en privat sector to th revise diagnosi an treatmen guide; on localitie nationwide.
V.
no
Scop of Applicatio pu
nationwide.
VI Definition of Term Combination Therapy:
(a) Artemisinin-base
combinatio
therap
(ACT): artemisinin
(b) Quinine+AL or QN+doxycycline/tetracycline/clindamyci
Confirmed Malaria:
bs
a)
icroscopy:
ed
Health Worker/Practitioner
Malari
Microscopists
Malari
Treatmen Failure:
ua
si
28
-t at
Severe Malaria:
othe
Uncomplicate
loca in ec ious diseases
Malaria: falciparum.
VII.
eneral
1.
idelines
Microscopy
ll cont nu to be he "gol standard fo diagnosing ma ar a. ll
Microscopy standard will be maintained by
qualit assuranc
system".
ea traine
microscopist in emergenc situation; he
Plasmodiu
falciparu
malaria, replacing CQ+SP combination;
et acyc in or do ycyc in th second-lin treatment.
or lindamyc
(Q
T/D/C
gast ic tube or in ravenous therapy) Artesuna (A suppositor nt oduced pendin rans er of patien to th next leve of ca e.vii
WH
or Good Manufacturin
health worker BH re er al reat en
Procedures (GMP certifications
or treatmen partner; of appropriat
pregnant an children be ow alaria areas;
ca be
e-orientat on an
an i-ma ar al
ad in stered by ra ne
heal
year old; re training
ll be conducte
especially
ende ic
Qualit Assuranc Guid an Standard will be develope as part of th Integrated Malari Contro Operations Guide Guidelines Hospital Care fo Children Efficacy an Safety of vii Clinical Review Evidence Behind th WH Artemisini Derivative in Children with Malaria. Joumal of Tropical Pediatrics 2006 52 (2):78-82. vi
Deve opment (C Ds an th
LG s.
nt -malaria drug wi be made avai able ox
be or sh ftin to AL
py
am
or al em FH ea th Philippine Integrated Diseas Surveillance an Response (PIDSR).
un
eg
VIII Ro es an
esponsib itie
respective catchmen provinces, cities an societ es NGOs an othe pr vate sector
executio
of hi
undertak
th followin
1. Lead amon
di
O:
tasks:
th dissem nation of th concerne
municipalities Suppor from professional il be mobilize an thei part cipation il
evised
ol cy an
uideline
on th Diagnosi
stakeholders
installation of essentia management system (e.g staf developmen program, logistic management reportin system qualit assurance, surveillance system
revise diagnostic an treatmen policy an guidelines when necessary;
1. Coordinate th timely procuremen an distribution of qualit anti-malaria drug Center fo Health Development 1. Ensure qual ty assuranc of diagnosi (m croscopy an DTs) an treatmen co laboration it he Bureau of Food an Drug (BFA ), esea ch Inst tute fo Tropical Medicine (RITM) an WH
collaboratio
with Center fo Health Developmen an th LGUs
ar en by th Health Policy Developmen an Planning Bureau
gno de
ne
1. Review he upda ed diagnostic an trea ment guidel ne as needed 1.
on to th pe formance of he CHDs ensu in co pl ance an adherenc of LG prov de (pub an private) to he revise diagnosi an reat en po ic and guidelines.
2. Procuremen
2. Undertak 2.
Division/Materia
Management Division
th timely procuremen of al anti-malaria commodities;
Ensure th proper storage, imel distribu io an de iver of co modi ie end-users
th
3. National Epidemiology Center (NEC
3. Provid accu ate, imel an comp et da as basi fo po ic decisions, strategi action an prioritization of resource an efforts; 3. Enhance/ma ns ream FHSI an
HILMIS as source fo tracking ma ar
case
lHe
both in-patient an out-patien care base on actuaria feasibilit B.
enters fo Health Developmen (CHD
advocate fo it adoption an implementation in he di ferent localities with respectiv regions;
he
th se of standa ds or confir ed mala ia diagnosis; bi on ng ab er ni drug an laboratory supplies utilization; (iv) maintainin stoc leve of medicine an othe co modi ie fo ou brea or emergenc si ua ions an v) main aining th Geimsa-stained preparation/productio center in strategically locate areas;
4. Mobi iz additional re ources policy an guidelines
trengthe
he
5. Formul te an implemen ad ocac plan particularly th loca officials. 6. En ur time
plementation of he ev se
enerat st keholders' support,
epor ng an su ve llance
7. Invest gate adve se reaction to th National Office
medicine an
prepare/subm
appropriat
epor
privat provider in differen localities in thei respective regions;
Loca
vern en
1. Provincial/Cit
it
Health Office (P/CHO
revise policy an guidelines on diagnosi an treatmen of malaria; stakeholders to adop an implemen th revise policy an guidelines 1.
Provid counterpar fundin fo training medicine an laboratory supplies within th province an monito utilizatio thereof;
requir regula inventor of stocks
othe system toward th efficien implementation of th policy an treatmen of malaria;
treatmen or or
onge period
necessary;
1. Mobilize additional resource fo th implementation of th revise diagnostic an treatmen guide; implementation of th policy 1.11 In estigate advers eact on to medicine an th regional BFAO
epor th sa
an guidelines in th public an privat facilities especially hospitals;
an
2. Implemen th revise diagnosi an treatmen po ic an guide; to PH 2.
ac
accordingly;
or
as
Provid laboratory confirmation of diagnosis; up er
i4
ar
ne
os
on
on
os
2. Ensure proper storag of anti-malar al drugs/othe co modities an make regula inventor of stocks
trainees; 2. Co lect analyz an submit report an
Ph IM
some prov nces as requ red;
trea ment guide;
2. Conduc an analyz client compliance survey
Volunteers 3. Conduc case findin
an supervis treatment; 51
cases;
ne
ci
3. Mobi iz co muni ie to us personal protection measures an to seek earl diagnosi fo provisio of effectiv treatment; 3. Report/refe adverse reaction immediately; er pe 3. Submit update
ar
on
ec
en
report regularly;
os 1.
rovide serv ce accord ng to qualit assuranc
2. Make availabl
protocol an guidel nes; and.
anti-malaria drug to privat practitioners.
E. Philippine Move en Agains alaria (PhilMAM an othe Non- overnmen Organization collaboratin with th Malari Contro Program.
As an implementing partner, ma undertak th followin
responsibilities
guid fo malaria; 2.
ov de suppor
heal
se vice de iver
prov de that approp ia
ra ning
as
government unit or community; 3.
ov de elevan expe ence system with communitie an
co
un ty ba ed
alar
on ro
de elop en
an ca increase politica support;
ocal go er ment unit in th
re ention nd on ro of
alaria
5. Assist in mobilizing resource fo additional medicine an laboratory supplies
pealin
la se
issuance inconsistent with th provisions of this issuance ar hereby rescinded.
X. Effectivity
This orde take effect immediately.
ecretary of Health
